MedPath

Genetic Information as a Life Style Change Motivator

Not Applicable
Completed
Conditions
Alzheimer Disease, Protection Against
Health Behavior
Interventions
Behavioral: information on the risk gene status
Behavioral: life style advise
Registration Number
NCT03794141
Lead Sponsor
Natural Resources Institute Finland
Brief Summary

The study investigates whether information on having a risk genotype (ApoE4) and life style advisory information affects lifestyle changes and sensory preferences. The project studies also the ethic aspects of giving the information of risk genotype.

Detailed Description

We will run intervention based on our earlier pilot study. It includes intensive intervention and a modification of our earlier pilot intervention. Our intervention methods are general lectures of the effects of healthy diet (Finnish Nutrition Recommendations 2014) and healthy lifestyle for all participants. Effects on motivation, attitudes and preferences will be studied and verified by questionnaires and risk factors of cardiovascular disease and Alzheimer disease by analyzing clinical markers of lipid metabolism, general phenotype markers and profiles of nutritional markers. Nutritional biomarkers will verify also the self-reported changes of diet in the questionnaires and in digital food diaries.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
333
Inclusion Criteria
  • Age between 40 and 60 years
  • overall good health (no chronic conditions e.g. mental disorders, cancer, liver or kidney disease, current or previous diagnosis),
  • body mass index (BMI) under 35 kg/m2,
  • blood pressure under 140/90 mmHg (medication allowed),
  • serum total cholesterol under 7.25 mmol/l (medication allowed)
  • fasting plasma glucose level under 7 mmol/l.
Exclusion Criteria
  • Abnormal values of the alanine amino transferase, alkaline phosphatase, haptoglobin and thyroid stimulating hormone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tervasinformation on the risk gene statusFollow up group from an earlier study. Information on risk gene status. All test persons were given information on healthy diet and life style.
Informedinformation on the risk gene statusInformation on risk gene status was given before intervention. All test persons were given information on healthy diet and life style.
Informedlife style adviseInformation on risk gene status was given before intervention. All test persons were given information on healthy diet and life style.
Tervaslife style adviseFollow up group from an earlier study. Information on risk gene status. All test persons were given information on healthy diet and life style.
non informedlife style adviseInformation on risk gene status was not given before intervention. All test persons were given information on healthy diet and life style.
Primary Outcome Measures
NameTimeMethod
serum APOE protein, mg/L2 years
serum brain-derived neurotrophic factor, ng/ml2 years
APOE and BDNF genotypebaseline
Serum Alanine aminotransferase, U/L2 years
Health concern, scale 1-92 years

1 not concerned at all

Waist circumference, cm2 years
serum Fatty acids, g/100g fatty acids2 years
Serum haptoglobin, g/L2 years
Plasma thyrotropin, mU/L2 years
blood pressure, mmHg2 years
Serum lipid peroxidation, MDA/µM2 years
Serum Alkaline phosphatase, U/L2 years
Food involvement and Food mavenism, scale 1-52 years

5 fully agree

Number of participants with good quality of dietary fat2 years

A questionnaire according to Finnish guidelines of Suomen Sydänliitto ry, Helldán \& Helakorpi, (2015)

Dietary habits, number of participants2 years

A questionnaire asking for

* Fish intake at least twice per week

* Consumption of high fat and sugar foods

* Consumption of vegetables

* Alcohol consumption

* Physical activity at least twice per week

Food choice questionnaire, health and taste attitude2 years

Scale 1-7 (7 most important, fully agree)

Life-orientation test, scale 1-52 years

1 fully agree

height m2 years
Visceral fat level (1-30)2 years
Serum Sensitive C reactive protein, mg/L2 years
Locus of Control, state-trait anxiety inventory, Three-Factor Eating Questionnaire (TFEQ) scale 1-42 years

4 fully agree

Serum lipid levels mmol/L2 years
Blood glucose levels, mmol/L2 years
weight kg2 years
Serum Hemoglobin, g/L2 years
serum Carotenoids, retinol and α-tocopherol, Plasma total phenolics ng/µl2 years
Blood cell count2 years
Secondary Outcome Measures
NameTimeMethod
Body mass index2 years

weight and height will be combined to report BMI in kg/m\^2

© Copyright 2025. All Rights Reserved by MedPath